Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902888 · ClinicalTrials.gov registry record
Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm
A clinical trial, sponsored by W.L.Gore & Associates.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01902888: Clinical Trial study, sponsored by W.L.Gore & Associates.
NCT01902888 is a clinical trial that was terminated before completion, run by W.L.Gore & Associates. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01902888 was terminated before completion, sponsored by W.L.Gore & Associates.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is a multicenter, non-randomized, single arm, retrospective study of GORE® VIABAHN® Endoprosthesis for the treatment of a Popliteal Artery Aneurysm (PAA).
Primary Outcome
A composite of freedom from failure of technical success or loss of primary patency at 12 months
Interventions
- DEVICE GORE® VIABAHN® Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-04 |
Why NCT01902888 stopped before completion
NCT01902888 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which GORE® VIABAHN® Endoprosthesis is the first listed.
NCT01902888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01902888 about?
NCT01902888 is a clinical study titled "Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm". This is a multicenter, non-randomized, single arm, retrospective study of GORE® VIABAHN® Endoprosthesis for the treatment of a Popliteal Artery Aneurysm (PAA).
What is the current status of trial NCT01902888?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2013-07. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01902888?
The interventions under investigation include: GORE® VIABAHN® Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT01902888?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia